What Onyx Scientific Ltd. does

Onyx Scientific Ltd. is a UK-based small molecule contract development and manufacturing organization (CDMO) founded in 2000 in Sunderland. It provides integrated chemistry, manufacturing, and controls (CMC) services to pharmaceutical and biotechnology companies spanning preclinical process research and development, non-GMP and GMP manufacturing, analytical services, solid-state chemistry, and commercial API supply. The company holds an MHRA commercial API manufacturing license, FDA compliance, and operates six ISO 8 classified GMP laboratories, enabling delivery of Phase I–III clinical materials and low-volume commercial drug substance — particularly for orphan drug and niche product applications. Customers range from virtual pharma companies and startup biotechs (Ferronova, NRG Therapeutics, Pluvia Biotech, Domain Therapeutics, Pharvaris, Mironid, Epics Therapeutics, Small Pharma, Nuformix) to larger organizations such as Cancer Research UK and consulting firms (Cerebro CMC, Skead Consulting), with multi-year engagements documented including a 14+ year client relationship.

The company's technical platform is built around process chemistry and solid-state chemistry expertise. Physical operations span two Sunderland sites — the Silverbriar headquarters (R&D, non-GMP custom synthesis, dedicated solid-state laboratories, analytical method development) and the Wayfarer manufacturing facility (four non-GMP kilo-laboratories each with four 50L vessels, and six MHRA-accredited ISO 8 GMP suites) — plus Pisgah Labs Inc. in North Carolina, USA (acquired 2017). Specialized material science equipment added in 2026 includes the Technobis Crystalline PV/RR Line (real-time particle imaging at 0.63 micron resolution), Crystal16 parallel screening, Buchi S300 mini spray dryer with ultrasonic nozzle for amorphous solid dispersions, Buchi Lyovapor L-250 Pro lyophilization system, and MC DecJet 30 jet mill for scalable micronization. The technical team is described as chemist-led with a leading UK solid-state group built over 10 years, specializing in challenging molecules including DCS Class II and IV compounds.

Onyx Scientific is a wholly-owned subsidiary of Ipca Laboratories Ltd., an Indian pharmaceutical company that acquired the firm in 2011, and operates as Ipca's CDMO division. Revenue is generated through project-based contract services (professional services model), with bespoke quotes tied to molecule complexity, scale, and phase requirements rather than publicly disclosed pricing. The go-to-market is direct B2B enterprise sales — consultative engagement at RFP stage with proposals tailored to specific project requirements — supported by business development managers covering UK/Europe and North America territories. Distribution is exclusively direct with no reseller or distributor channels, and marketing is conducted via LinkedIn, a content-driven knowledge hub, whitepapers, industry events, and virtual site tours.

Name

Onyx Scientific Ltd.

Legal name

Onyx Scientific Limited

Website

http://onyxipca.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

51–100 employees

Short description

Onyx Scientific is a UK-based small molecule CDMO that provides integrated chemistry, manufacturing, and controls (CMC) services — from preclinical process development through GMP and commercial API manufacturing — to pharmaceutical and biotechnology companies.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing (CDMO)

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Small-Molecule API & Intermediates CDMO (HLAGABAA)

akta.pro secondary industries

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB), Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)

Keywords

• Small molecule CDMO
• API development
• GMP manufacturing
• Process chemistry
• Solid state chemistry

Headquarters

HQ city

Sunderland

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Contract Development and Manufacturing Services: Project-based contract services for API development and manufacturing across preclinical, clinical (Phase I-III), and commercial phases. Revenue generated through bespoke project fees, scale-up campaigns, and manufacturing batches. Services include process research & development, GMP manufacturing, analytical services, and solid-state chemistry.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Onyx Scientific Ltd. is a contract development and manufacturing organization (CDMO) for small molecule active pharmaceutical ingredients (APIs), providing integrated CMC services spanning process research and development, non-GMP scale-up, GMP manufacturing for Phase I-III clinical materials, analytical services, and solid-state chemistry. The company operates from MHRA-accredited facilities in Sunderland, UK (Silverbriar and Wayfarer sites) and Pisgah Forest, North Carolina, delivering bespoke projects from preclinical through commercial supply. It operates as the CDMO division of Ipca Laboratories Ltd.

Product overview

Onyx Scientific is a small molecule CDMO (Contract Development and Manufacturing Organization) offering integrated CMC services from preclinical through commercial manufacturing. Their service portfolio includes Process Research & Development, GMP Manufacturing, Analytical Services, Solid State Chemistry (salt/co-crystal screening, polymorphism, crystallization development), and Commercial API manufacturing. The company operates facilities in Sunderland, UK (Silverbriar and Wayfarer sites) and North Carolina, US (via Pisgah Labs Inc.), and is the CDMO division of Ipca Laboratories. Services are delivered through a chemist-led, phase-appropriate approach with integrated departments working collaboratively from lead nomination through commercial supply.

Differentiator

Problem solved

Functional benefit

Products and services

• Process Research & Development (PR&D)

Quantifiable outcome

• Scale-up capacity increased by 50% through facility expansion
• +3 more outcomes

Named customers13 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Scale indicators12 records

Recent moves10 records

Expansion highlights6 records

Emerging players

• Neuland Laboratories: India-based API manufacturer and CDMO offering similar small molecule API services with cost advantages from Indian operations, comparable to Ipca's parent positioning.
• Sai Life Sciences: India-based CDMO offering small molecule API development and GMP manufacturing with comparable services, emerging as a cost-competitive alternative for global biotech clients.

Broad incumbents

• Lonza Small Molecules: Global CDMO leader with substantial small molecule API development and manufacturing capabilities, serving as the scale benchmark that defines Onyx's niche positioning.
• EUROAPI: Sanofi-spinoff API manufacturer and CDMO serving European and global pharma with broader product portfolio and larger commercial API scale than Onyx.

Direct peers

• Corden Pharma: European-headquartered CDMO offering small molecule API development and manufacturing with comparable MHRA/FDA-credentialed GMP infrastructure and pharmaceutical customer base.
• Hovione: Portugal-based small molecule CDMO specializing in API development, solid-state chemistry, and particle engineering with similar integrated service model and pharmaceutical customer base.
• Alcami Corporation: US-based CDMO offering small molecule API development, GMP manufacturing, and analytical services with comparable scale and similar pharmaceutical/biotech customer profile.
• Cambrex: Small molecule API CDMO with similar service portfolio spanning drug substance development through commercial manufacturing, currently operating under Symeres ownership.
• AGC Pharma Chemicals: European small molecule API CDMO with cGMP manufacturing, solid form services, and similar integrated CMC offerings targeting pharma and biotech customers.
• Sterling Pharma Solutions: UK-headquartered small molecule API CDMO offering similar integrated CMC services from preclinical through commercial, with comparable employee scale and MHRA/FDA regulatory credentials.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/onyx-scientific-ltd
• Xx.com/onyxscientific1

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Onyx Scientific Ltd.